- Home
- EVMN vs CURI Comparison
EVMN vs CURI Comparison
Compare EVMN & CURI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EVMN | CURI |
|---|---|---|
| Founded | 2020 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 185.1M | 153.7M |
| IPO Year | 2025 | 2019 |
Fundamental Metrics
Financial Performance| Metric | EVMN | CURI |
|---|---|---|
| Price | $6.82 | $2.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | ★ $22.33 | $5.33 |
| AVG Volume (30 Days) | ★ 911.5K | 497.6K |
| Earning Date | 11-16-2026 | 11-11-2026 |
| Dividend Yield | N/A | ★ 12.78% |
| EPS Growth | ★ 75.23 | 54.17 |
| EPS | N/A | ★ 0.12 |
| Revenue | $13,000,000.00 | ★ $78,043,000.00 |
| Revenue This Year | N/A | $10.59 |
| Revenue Next Year | N/A | $12.05 |
| P/E Ratio | ★ N/A | $22.17 |
| Revenue Growth | ★ 85.71 | 9.52 |
| 52 Week Low | $4.94 | $2.30 |
| 52 Week High | $33.20 | $5.10 |
Technical Indicators
Market Signals| Indicator | EVMN | CURI |
|---|---|---|
| Relative Strength Index (RSI) | 42.35 | 46.39 |
| Support Level | $4.94 | $2.55 |
| Resistance Level | $7.21 | $2.96 |
| Average True Range (ATR) | 0.59 | 0.13 |
| MACD | 0.27 | -0.02 |
| Stochastic Oscillator | 48.46 | 38.82 |
Price Performance
Historical ComparisonAbout EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.
About CURI CuriosityStream Inc.
CuriosityStream Inc is a media and entertainment company. It offers premium video programming across the principal categories of factual entertainment, including science, history, society, nature, lifestyle, and technology. The firm's products and services are Direct to Consumer Business, Partner Direct Business, Bundled Distribution, Content Licensing, and Others. The majority of the revenue comes from the direct business and Content licensing. Geographically, the company generates the majority of its revenue from the United States.